Pharvaris N.V. - Ordinary shares, par value Euro 0.12 per share (PHVS)

CUSIP: N69605108

Q2 2024 13F Holders as of 30 Jun 2024

Holder snapshot 6 signals
Share change
+583,023
SEC-reported price per share
$18.80
Number of holders
36
Value change
+$10,680,383
Number of buys
15
Number of sells
13
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
70,522,724

Security key

N69605108

Report period

Q2 2024

Institutions

36

Top holders

10

Ownership snapshot

Top reported holders of PHVS - Pharvaris N.V. - Ordinary shares, par value Euro 0.12 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
GENERAL ATLANTIC, L.P.
Disclosed value leader
GENERAL ATLANTIC, L.P.
Comparable rows
0/15
Latest evidence
31 Mar 2024
13F Highest disclosed value: $174,047,234 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

GENERAL ATLANTIC, L.P. has the largest disclosed position value at $174.05M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens GENERAL ATLANTIC, L.P.'s linked filing trail.
Disclosed position value Top 5
GENERAL ATLANTIC, L.P. $174.05M
FMR LLC $120.01M
venBio Partners LLC $99.13M
Foresite Capital Management IV, LLC $93.34M
VIKING GLOBAL INVESTORS LP $84.43M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
GENERAL ATLANTIC, L.P.
13F
Company
13F
—
denominator unverified
$174,047,234
7,531,252 shares
— 31 Mar 2024
FMR LLC
13F
Company
13F
—
denominator unverified
$120,009,860
5,192,984 shares
— 31 Mar 2024
venBio Partners LLC
13F
Company
13F
—
denominator unverified
$99,125,815
4,289,304 shares
— 31 Mar 2024
Foresite Capital Management IV, LLC
13F
Company
13F
—
denominator unverified
$93,337,639
4,038,842 shares
— 31 Mar 2024
VIKING GLOBAL INVESTORS LP
13F
Company
13F
—
denominator unverified
$84,427,994
3,653,310 shares
— 31 Mar 2024
Venrock Adviser, LLC
13F
Company
13F
—
denominator unverified
$78,472,455
3,395,606 shares
— 31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
36
Shares
43,008,763
Rows available
36
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q3 2025 Across Filers

Q3 2025 holders
83
Q2 2024 holders
36
Holder diff
-47
Investor Q3 2025 Shares Q2 2024 Shares Share Diff Share Chg % Q3 2025 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .